Northwestern Mutual’s Matt Stucky joins TheStreet to break down small caps, market rotation, AI disruption risks and his 2026 ...
Michael H. Carrel: 2025 was an exceptional year at AtriCure, Inc. with achievements across our business. This trial is evaluating the benefit of our AtriClip devices on non-AFib patients undergoing ...
Sean T. Saint: and I want to take a brief moment to reflect on it before we dive into the details of our Q4 and full year 2025 performance. Beta Bionics, Inc. exists to deliver solutions to people ...